tiprankstipranks
Archer Materials Limited (AU:AXE)
ASX:AXE
Want to see AU:AXE full AI Analyst Report?

Archer Materials (AXE) AI Stock Analysis

45 Followers

Top Page

AU:AXE

Archer Materials

(Sydney:AXE)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 5.2)
Rating:41Neutral
Price Target:
AU$0.24
â–¼(-30.29% Downside)
Action:Reiterated
Date:07/08/26
The score is held down primarily by weak financial performance (declining revenue, ongoing losses, and pressured cash flow), reinforced by bearish technical signals (below major moving averages and negative MACD). Valuation does not provide support because the company is loss-making (negative P/E) and no dividend yield is available.
Positive Factors
Proprietary Quantum Technology
Archer’s focus on a carbon-based 12CQ quantum chip establishes a specialized, high-barrier technology pathway. That IP-centric business model supports long-term optionality, potential partnerships with fabs and research institutions, and a differentiated position in quantum semiconductors.
Negative Factors
Declining Revenue
Revenue contraction of nearly 11% signals weakening commercial traction or delayed product commercialization. Persistent top-line decline undermines operating leverage and makes it harder to absorb fixed R&D and G&A costs, lengthening the path to sustainable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Proprietary Quantum Technology
Archer’s focus on a carbon-based 12CQ quantum chip establishes a specialized, high-barrier technology pathway. That IP-centric business model supports long-term optionality, potential partnerships with fabs and research institutions, and a differentiated position in quantum semiconductors.
Read all positive factors

Archer Materials (AXE) vs. iShares MSCI Australia ETF (EWA)

Archer Materials Business Overview & Revenue Model

Company Description
Archer Materials Limited is an Australian technology company dedicated to the advancement and commercialization of semiconductor devices and sophisticated processor chips. Its work primarily targets applications in quantum computing and medical di...
How the Company Makes Money
null...

Archer Materials Financial Statement Overview

Summary
Weak fundamentals driven by declining revenue (-10.98% latest year) and persistent losses (net margin -3.39%) with negative EBIT/EBITDA margins. Balance sheet leverage is minimal (debt-to-equity 0.0009), but returns are poor (ROE -41.70%). Cash generation is also under pressure with negative free cash flow growth (-4.38%).
Income Statement
35
Negative
Balance Sheet
45
Neutral
Cash Flow
40
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue845.89K2.06M2.14M1.50M973.00K467.66K
Gross Profit795.39K2.06M2.14M-53.74K922.59K435.36K
EBITDA-7.74M-6.94M-5.11M-8.66M-14.97M-3.24M
Net Income-5.55M-6.97M-4.80M-9.05M-14.12M-7.84M
Balance Sheet
Total Assets14.87M17.47M22.89M27.21M30.17M19.69M
Cash, Cash Equivalents and Short-Term Investments10.32M13.82M18.78M24.19M28.17M8.93M
Total Debt6.90K14.97K109.31K9.10K19.75K30.09K
Total Liabilities909.76K752.16K1.09M1.21M746.23K732.71K
Stockholders Equity13.96M16.72M21.80M26.00M29.42M18.96M
Cash Flow
Free Cash Flow-6.47M-4.19M-4.99M-3.21M-4.44M-2.32M
Operating Cash Flow-6.45M-4.19M-4.79M-3.03M-4.30M-2.22M
Investing Cash Flow9.38M4.11M6.98M2.31M-94.83K-262.25K
Financing Cash Flow-18.73K-96.30K-115.82K64.90K24.62M606.22K

Archer Materials Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.35
Price Trends
50DMA
0.33
Negative
100DMA
0.33
Negative
200DMA
0.35
Negative
Market Momentum
MACD
-0.02
Positive
RSI
31.53
Neutral
STOCH
15.87
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AXE, the sentiment is Negative. The current price of 0.35 is above the 20-day moving average (MA) of 0.31, above the 50-day MA of 0.33, and above the 200-day MA of 0.35, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 31.53 is Neutral, neither overbought nor oversold. The STOCH value of 15.87 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:AXE.

Archer Materials Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
52
Neutral
AU$1.88B-32.06-57.61%―508.63%-6.35%
48
Neutral
AU$338.12M-10.58-89.98%―386.28%21.47%
46
Neutral
AU$64.61M-3.88-99.85%―2.41%23.50%
43
Neutral
AU$22.67M-4.07-86.80%――7.50%
41
Neutral
AU$71.46M-10.78-36.17%――13.49%
41
Neutral
AU$1.59B-29.40-27.53%―64.95%-31.63%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:AXE
Archer Materials
0.24
-0.05
-16.07%
AU:BRN
BrainChip Holdings
0.15
-0.05
-25.00%
AU:BLG
BluGlass
0.33
0.13
65.83%
AU:4DS
4DS Memory
0.01
-0.02
-59.26%
AU:SLX
Silex Systems Limited
5.25
1.08
25.90%
AU:WBT
Weebit Nano Ltd.
7.00
5.14
275.34%

Archer Materials Corporate Events

Archer Materials Launches Share Purchase Plan to Fund Quantum Expansion
Jul 9, 2026
Archer Materials has dispatched the offer booklet for its share purchase plan, inviting eligible shareholders in Australia and New Zealand to subscribe for up to A$30,000 of new shares at A$0.27 per share, matching the price of a recent placement....
Archer Materials Seeks ASX Quotation for 25.4 Million New Shares
Jul 8, 2026
Archer Materials Limited has applied to the ASX for quotation of 25,407,416 ordinary fully paid shares under its existing issuer code AXE. The new securities, issued on July 9, 2026, form part of previously announced transactions and will expand t...
Archer Materials Advances Quantum Chip and Biochip Programs, Raises Capital for Growth
Jul 8, 2026
Archer Materials reported a strong fourth quarter, highlighting full-wafer manufacturing runs of refined graphene spin qubit designs for its 12CQ quantum chip. This marks progress toward demonstrating a functional qubit and scaling the technology ...
Archer Materials to Brief Investors on IonQ Partnership and Quantum Strategy
Jul 3, 2026
Archer Materials will host a special investor webinar on 7 July 2026 to update shareholders on its strategic partnership with U.S.-listed quantum leader IonQ and to discuss its ongoing Share Purchase Plan offer. The virtual briefing, led by CEO Dr...
Archer Materials Unveils Major Share and Option Issue on ASX
Jul 3, 2026
Archer Materials Limited has outlined plans for a significant equity raising through a combination of a securities purchase plan and placements of ordinary shares and options. The proposed issue includes tens of millions of new ordinary fully paid...
Archer Materials outlines capital raising push for quantum partnership with IonQ
Jul 3, 2026
Archer Materials has outlined a capital raising presentation in July 2026 centred on a strategic compute and capability partnership with U.S.-listed quantum computing firm IonQ. The initiative is framed as part of the company’s effort to bri...
Archer raises A$7m, launches SPP to fund IonQ quantum deal
Jul 3, 2026
Archer Materials has secured binding commitments for a two‑tranche equity placement raising A$7 million and launched a share purchase plan of up to A$3 million at A$0.27 per share, supported by institutional and sophisticated investors as we...
Archer strikes IonQ deal to boost sovereign quantum ambitions
Jul 1, 2026
Archer Materials has signed a strategic Quantum Compute Agreement with U.S.-listed IonQ, giving it access to IonQ’s Quantum Cloud and specialist engineering support to develop quantum algorithms and applications. The partnership positions Ar...
Archer Materials Requests Trading Halt Ahead of Capital Raising
Jul 1, 2026
Archer Materials has requested a trading halt on its ASX-listed securities as it prepares to announce a material capital raising, prompting ASX Compliance to suspend trading until the news is released or normal trading resumes on 3 July 2026. The ...
Archer Materials Lapses 57,286 Performance Rights After Unmet Conditions
Jun 26, 2026
Archer Materials Limited has announced the lapse of 57,286 performance rights, which have ceased because the conditions attached to these rights were not met or could no longer be satisfied. The cessation of these securities reflects an adjustment...
Archer Marks Quantum Milestone in Fraud Detection Push
Jun 4, 2026
Archer Materials has completed the latest phase of its quantum machine learning fraud detection project, successfully developing and benchmarking a quantum neural network model on a large, publicly available financial transaction dataset. The mode...
Archer Materials Reports Lapse of 118,151 Performance Rights
May 21, 2026
Archer Materials Limited has announced the lapse of 118,151 performance rights, which ceased on 20 May 2026 because the conditions attached to these conditional rights were not satisfied or became incapable of being satisfied. The change, disclose...
Archer Materials advances toward wafer-scale quantum device manufacturing
May 11, 2026
Archer Materials is progressing its graphene-based quantum device program from laboratory-scale prototypes toward wafer-scale semiconductor manufacturing. The company remains on track to demonstrate a working qubit this year, positioning itself as...
Archer Materials Schedules Investor Webinar for March Quarter Update
May 3, 2026
Archer Materials will host an investor webinar to deliver its quarterly update for the period ended 31 March 2026, with Chief Executive Officer Dr Simon Ruffell presenting on 5 May 2026 and taking investor questions. The event underscores Archer&#...
Archer Materials Advances Qubit, QML, and Biochip Programs in Q3 FY26
Apr 29, 2026
Archer Materials reported progress in Q3 FY26 across its quantum computing and sensing platforms, advancing development of a carbon-based qubit device by improving readout and control via single-electron transistors and scaling carbon material gro...
Archer Materials Reports Lapse of 146,077 Performance Rights
Apr 22, 2026
Archer Materials Limited has notified the market of the lapse of 146,077 performance rights, which have ceased because the conditions attached to these conditional rights were not met or became incapable of being satisfied as of April 21, 2026. Th...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 08, 2026